Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-24T12:34:43.628Z Has data issue: false hasContentIssue false
  • English
  • Français

Tricuspid valve in valve procedure with an Edwards S3 valve© in a 10 kg child

Published online by Cambridge University Press:  07 October 2020

Pedro Betrián-Blasco Open the ORCID record for Pedro Betrián-Blasco [Opens in a new window] ,
Gerard Marti-Aguasca  and
Gemma Giralt-García
Pedro Betrián-Blasco*
Affiliation:
Pediatric Interventional Cardiology, Valle de Hebrón Hospital, Barcelona, Spain
Gerard Marti-Aguasca
Affiliation:
Pediatric Interventional Cardiology, Valle de Hebrón Hospital, Barcelona, Spain
Gemma Giralt-García
Affiliation:
Pediatric Cardiac Imaging Unit, Valle de Hebrón Hospital, Barcelona, Spain
*
Author for correspondence: Pedro Betrián-Blasco MD, PhD, Paseo de Valle de Hebrón 119–129, Barcelona08035, Spain. Tel: +34 932746155; Fax: +34 932746001. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

A 4-year-old child of 10 kg weight, with four previous sternotomies, presented a severe right heart failure, due to a severe regurgitation of his bioprosthetic tricuspid valve. A percutaneous tricuspid valve in valve procedure with an Edwards S3 valve was offered for compassionate use, and performed, with no complications, and significant clinical condition improvement.

Keywords

Tricuspid valve diseasecongenital heart diseasetranscatheter valve implantationpaediatric intervention
Type
Brief Report
Information
Cardiology in the Young , Volume 31 , Issue 1 , January 2021 , pp. 135 - 137
Check for updates
Copyright
© The Author(s), 2020. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Fernandez-Doblas, J, Perez-Andreu, J, Betrian, P, et al. Pediatric tricuspid valve replacement with transcatheter bioprosthetic valve: an alternative option in high-risk patients. Semin Thorac Cardiovasc Surg 2019. doi: 10.1053/j.semtcvs.2019.06.006 Google ScholarPubMed
Challa, A, Markham, R, Walters, D. Percutaneous valve in valve in the tricuspid position in a patient with Tetralogy of Fallot. BMJ Case Rep 2017. doi: 10.1136/bcr-2017-221104 CrossRefGoogle Scholar
McElhinney, DB, Cabalka, AK, Aboulhosn, JA, et al. Transcatheter tricuspid valve-in-valve implantation for the treatment of dysfunctional surgical bioprosthetic valves: an international, multicenter registry study. Circulation 2016; 133: 1582–1593. doi: 10.1161/CIRCULATIONAHA.115.019353 CrossRefGoogle ScholarPubMed
Scarsini, R, Lunardi, M, Pesarini, G, et al. Long-term follow-up after trans-catheter tricuspid valve-in-valve replacement with balloon-expandable aortic valves. Int J Cardiol 2017; 235: 141–146. doi: 10.1016/j.ijcard.2017.02.076 CrossRefGoogle ScholarPubMed
Cools, B, Rega, F, Gewillig, M. Transhepatic implant of a trimmed Melody™ valved stent in tricuspid position in a 1-year-old infant. Catheter Cardiovasc Interv 2017; 89: E84–E89. doi: 10.1002/ccd.26672 CrossRefGoogle Scholar

Betrián-Blasco et al. supplementary material

Betrián-Blasco et al. supplementary material 1

Download Betrián-Blasco et al. supplementary material(Video)
Video 18.4 MB

Betrián-Blasco et al. supplementary material

Betrián-Blasco et al. supplementary material 2

Download Betrián-Blasco et al. supplementary material(Video)
Video 11.9 MB